AAAAAA
Results:
1-7
|
Results: 7
Authors:
Komers, R
Anderson, S
Epstein, M
Citation: R. Komers et al., Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors, AM J KIDNEY, 38(6), 2001, pp. 1145-1157
Authors:
Komers, R
Komersova, K
Citation: R. Komers et K. Komersova, Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes, EXPERT OP I, 9(11), 2000, pp. 2601-2617
Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?
Authors:
Komers, R
Anderson, S
Citation: R. Komers et S. Anderson, Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?, CURR OP NEP, 9(2), 2000, pp. 173-179
Authors:
Komers, R
Lindsley, JN
Oyama, TT
Allison, KM
Anderson, S
Citation: R. Komers et al., Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renalhemodynamic changes in diabetes, AM J P-REN, 279(3), 2000, pp. F573-F583
Authors:
Komers, R
Komersova, K
Kazdova, L
Ruzickova, J
Pelikanova, T
Citation: R. Komers et al., Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans, J HYPERTENS, 18(1), 2000, pp. 51-59
Authors:
Komers, R
Oyama, TT
Chapman, JG
Allison, KM
Anderson, S
Citation: R. Komers et al., Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats, HYPERTENSIO, 35(2), 2000, pp. 655-661
Authors:
Komers, R
Pelikanova, T
Kazdova, L
Citation: R. Komers et al., Effect of hyperinsulinaemia on renal function and nitrate/nitrite excretion in healthy subjects, CLIN EXP PH, 26(4), 1999, pp. 336-341
Risultati:
1-7
|